Breaking news

Engineering New Consciousness: Science Corp. And The Future Of Brain-Computer Interfaces

by THEFUTURE.TEAM

From Anecdote to Ambition

Six years ago, at a StrictlyVC event in San Francisco, Sam Altman famously remarked that one day OpenAI’s financial model might be answered by the AI itself. His confident vision, shared amid skeptical laughter, foreshadowed a landscape where technology and commerce intersect in unexpected ways. This early declaration resonates today as innovators push the boundaries of what brain-computer interfaces (BCIs) can achieve.

Max Hodak and a Revolutionary Journey

At a recent event, Max Hodak, co-founder and CEO of Science Corp., embodied a blend of youthful irreverence and technological foresight that belies his company’s market valuation running into the hundreds of millions. With programming roots tracing back to age six and formative experiences at Duke working with neuroscientist Miguel Nicolelis, Hodak’s career trajectory has been as unconventional as it is impactful. His tenure as president of Neuralink alongside Elon Musk laid a robust foundation for groundbreaking operational strategies, with Musk’s decisive approach often crystallizing complex technical dilemmas into pragmatic solutions.

Commercial Viability Meets Advanced Engineering

Drawing on lessons from his Neuralink experience, Hodak and his team at Science Corp. have sought to balance audacious ambitions with concrete revenue generation. Their flagship procedure, Prima, exemplifies this balance. By refining a retinal implant technology originally developed by French firm Synchron—which restored form vision in patients with advanced macular degeneration—Science Corp. has demonstrated that disruptive innovation can be both life-changing and commercially viable. Clinical trials have shown promising results, with nearly 80% of participants regaining the ability to read, however incrementally.

Innovation in Gene Therapy and Beyond

Beyond electrical neuromodulation, Science Corp. is venturing into the realm of optogenetic gene therapy. By reengineering surviving retinal cells to respond directly to light and thereby bypass traditional electrode stimulation, the company is pioneering a method that could redefine the interface between human biology and technology. In Hodak’s words, the state-of-the-art proteins employed in their research outperform conventional approaches in speed and sensitivity, positioning Science Corp. at the forefront of a sector poised to transform human consciousness.

Scaling Up and the Future of Consciousness

Hodak is not content with incremental advances. With ambitious plans to extend the scalability of BCI technologies—potentially even incorporating gene therapy and biohybrid neural interfaces—the ultimate goal is to unravel the mysteries of consciousness itself. His vision encompasses a future where the integration of multiple brains, devices, and artificial constructs could redefine the boundaries of identity. Though such prospects might evoke dystopian imagery reminiscent of speculative fiction, Hodak’s measured projections underscore concrete timelines and regulatory pathways, suggesting that the convergence of biology and technology is nearing a critical tipping point.

Economic and Societal Implications

While the imminent deployment of these technologies raises questions about regulatory oversight and economic stratification, Hodak is acutely aware of the broader implications. As healthcare systems struggle with fixed funding models and escalating costs, the eventual widespread adoption of BCIs may necessitate a complete reevaluation of how society values cognitive enhancement and longevity. This paradigm shift could transform everything from patient care to global economic dynamics, laying the groundwork for a future where advantages in cognitive function translate directly into competitive and financial disparities.

A Cautious Look Ahead

As science continues to challenge the very essence of human experience, the debates surrounding BCIs remain as much about ethics and control as about engineering and revenue. While Hodak is confident that these technologies will be built—and eventually become routine for patients in need by 2035—the potential for unforeseen social and economic impacts remains a critical concern. The conversation is no longer a speculative side note; it is a pressing examination of how far technology can—and should—reshape what it means to be human.

Conclusion

In the end, what began as a provocative remark by Altman has evolved into a rigorous pursuit of merging human consciousness with computational innovation. With Science Corp. leading the charge, the future promises both unprecedented medical breakthroughs and challenges that will require robust regulatory, ethical, and economic frameworks. As we stand on the verge of integrating minds with machines, the stakes have never been higher.

Women Make Up A Majority Of The EU’s Science And Technology Workforce But The Real Gap Is Elsewhere

by News Editor

Women now make up the majority of the EU’s science and technology workforce. According to Eurostat, in 2025, more than 81.6 million people aged 15 to 74 were employed in science and technology occupations across the EU. Of those, 52.5% were women, equal to 42.8 million women. The number of women in these occupations rose by 27.9% compared with 2015, an increase of more than 9.3 million over a decade.

On the surface, the numbers resemble progress. However, Eurostat’s category requires context before that figure can be read accurately. The data refers to HRST, or Human Resources in Science and Technology, specifically people employed in science and technology occupations. These are roles where the main tasks require professional or technical knowledge in physical and life sciences, but also in social sciences and humanities. That definition is wider and broader than engineering, ICT, laboratory science, or high-tech research alone.

Zooming In

The gender picture changes once the data moves from a wider definition of the workforce to the narrower scientist-and-engineer (research and manufacturing) subgroup.

Scientists and engineers represented almost a quarter of all people employed in science and technology in the EU in 2025. Eurostat describes scientists and engineers as often being the innovators at the centre of technology-led development, making them an important subgroup to focus on separately.

Women accounted for only 40.8% of scientists and engineers in 2025, despite making up more than half of the wider category. That share has increased by a mere 0.5 percentage points over the past decade. The absolute number of women working as scientists and engineers rose from 5.3 million in 2015 to 8.2 million in 2025, despite the push from national and international organisations to increase the number of women in the field. Europe has expanded the number of women in science and technology occupations over ten years. However, that expansion has not extended equally into the scientist-and-engineer subgroup, where much of Europe’s research and innovation work is conducted.

In 2025, of the 39.4 million women aged 25 to 64 working in science and technology occupations in the EU, 35.5 million worked in service activities. Only 2.7 million worked in manufacturing. Women accounted for 57.5% of science and technology employment in services, but only 31.3% in manufacturing.

In 2025, the highest shares of women employed in science and technology occupations were recorded in Latvia at 62.4%, followed by Hungary’s Great Plain and North region at 61.1%, Estonia at 60.5%, Poland’s Central macroregion at 60.4%, and Lithuania at 60.3%. No EU country recorded a majority of women among science and technology workers in manufacturing.

Break-down

Eurostat’s figures measure employment in broad science and technology occupations. They do not show job security, pay levels, management roles, promotion rates, research leadership, or whether women are concentrated in junior or senior workplace positions.

The classification of “senior” also requires additional explanation. Eurostat reports that 45.9% of science and technology workers aged 25 to 64 in the EU were classified as “senior” HRST in 2025. In this dataset, “senior” refers to workers aged 45 to 64. It does not mean senior manager, senior researcher, team lead, or decision-maker.

A high female share in the wider Human Resource Science and Technology (HRST) category does not parallel equal representation across scientists, engineers, manufacturing roles, senior posts, pay, research funding, or decision-making. These figures also reflect the occupational mix inside each country or region, not only structural progress across all areas of science and technology.

The Case Of Cyprus

Eurostat data places Cyprus’s overall science and technology employment at 37.2% of the labour force in 2025, slightly above the EU-27 figure of 36.9%, and above Greece at 26.8%, Malta at 33.9%, and Turkey at 18.2%. This figure covers the total share of the labour force employed in science and technology across all genders.

Progress Or Work-in-Progress?

52.5% in the broad category. 40.8% among scientists and engineers. 31.3% in manufacturing. Europe’s gender gap in science and technology hasn’t closed yet, and there is still work to be done to encourage and support more women to enter the field, especially in research and manufacturing.

Let’s not wait another decade for another couple of percentage points of hope.

Uol
The Future Forbes Realty Global Properties
eCredo
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter